期刊文献+

急诊经冠脉自体骨髓单个核细胞移植治疗急性下壁心肌梗死长期随访观察 被引量:19

Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction
原文传递
导出
摘要 目的采用前瞻性随机对照研究方法,评价经冠状动脉自体骨髓单个核细胞(BM-MNC)移植治疗急性下壁心肌梗死后6个月时患者心功能以及心肌缺血面积的变化。方法40例首次ST段抬高急性下壁心肌梗死患者,成功完成PCI术后,随机分为细胞移植组(n=20)和对照组(n=20),在急诊冠状动脉造影术同时,经微导管于梗死相关动脉内支架远端注入自体BM-MNC悬液或等量的肝素生理盐水。研究终点为术后6月时延迟增强核磁共振心肌灌注扫描(CMR)测定左室功能和心肌缺血面积。结果CMR记录左室射血分数(LVEF)、左室舒张末期容积(LVEDV)及心肌缺血面积的变化,结果显示与术前相比,两组患者LVEF均有显著提高(对照组47·9%±6·7%vs43·4%±6·7%,P=0·001;细胞移植组51·5%±5·2%vs44·5%±7·1%,P=0·001)。但细胞移植组患者LVEF升高程度(△LVEF)增加明显高于对照组LVEF改善程度(6·95%±3·33%vs4·05%±1·68%,P=0·047),且细胞移植组患者心肌缺血面积减少程度优于对照组,两组间左室舒张末容积变化未见明显差别。结论急性下壁心肌梗死患者经冠状动脉内自体骨髓单个核细胞移植,可显著长期改善患者左室收缩功能和心肌灌注,减少心肌缺血面积。 Objective To investigate the effects of emergent intracoronary autologous bone marrow mononuclear cell (BM-MNC) transplantation on left ventricular function and myocardium lesion area in patients with first acute inferior-wall myocardial infarction. Methods Forty patients with first onset of acute inferior-wall myocardial infarction, 28 males and 12 females, aged ≤75, treated with emergent percutaneous coronary intervention (PCI) were randomly divided into 2 equal groups: group undergoing intracoronary transplantation of autologous BM-MNC via a micro-catheter right after PCI ( BM-MNC group), and control group receiving normal saline and heparin. Blood routine examination, myocardium zymogram, and serum high sensitive C reactive protein (hsCRP) were detected, and 24-hour dynamic electrocardiography, delayed-enhancement myocardial magnetic resonance imaging (CMR), and angiography of the coronary artery and left ventricle were conducted before the transplantation and immediately, 1 week, and 6 months after transplantation. Results CMR showed that 6 months later the left ventricular ejection fraction (LVEF) of the control group was 47.9% ± 6.7%, significantly higher than that 1 week later (43.4% ± 6.7% ,P =0.001 ), and the LVEF of the BM-MNC group 6 months later was 51.5% ±5.2%, significantly higher than that 1 week later (44. 5% ± 7. 1%,P =0. 001; however, the absolute change of LVEF (ALVEF) of the BM-MNC group was 6.95% ±3.33% , significantly higher than that of the control group (4.05% ± 1.68% , P = 0. 047 ). Six months later the myocardial lesion area of the BM-MNC group decreased more significantly in comparison with the control group. Nevertheless, there was no difference in change of left ventricular end diastolic volume (LVEDV) between these two groups. The serum hsCRP 48 h after transplantation of the BM-MNC group was 2.8 g/L ± 0.8 g/L, significantly lower than that before transplantation (13.4 g/L ± 3.6 g/L, P 〈 0. 001 ). ± No severe clinical events, such death, recurrent cardiac infarction, malignant arrhythmia, occur in these 2 groups. Conclusion Emergent intracoronary transplantation of autologous BM-MNC in patients with acute inferior-wall myocardial infarction improves the left ventricular function and myocardial infusion, minimizes the myocardial lesion area significantly.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第16期1107-1110,共4页 National Medical Journal of China
基金 国家"十五"科技攻关计划基金资助项目(2004BA714B05-2)
关键词 心肌梗塞 单个核细胞 细胞移植 心室功能 磁共振波谱学 长期随访 经冠脉自体骨髓单个核细胞移植 Myocardial infarction Mononuclear cell Cell transplantation Ventricular function Magnetic resonance spcetroscopy
  • 相关文献

参考文献9

  • 1Wollert KC.Intracoronary autologous bone-marrow cell transfer after myocardial infarction:the BOOST randomised controlled clinical trial.Lancet,2004,364:141-148.
  • 2Assmus B,Schachinger V,Teupe C,et al.Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).Circulation.2002,106:3009-3017.
  • 3李延林,葛均波,钱菊英,史剑慧,王齐兵,牛玉宏,潘翠珍,樊冰,刘学波,张少衡,孙爱军,邹云增.急诊经冠状动脉自体骨髓单个核细胞移植治疗急性心肌梗死的临床研究[J].中国介入心脏病学杂志,2005,13(3):142-145. 被引量:29
  • 4高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4948
  • 5Angoulvant D.Neovascularization derived from cell transplantation in ischemic myocardium.Mol Cell Biochem,2004,264:133-142.
  • 6Heil M,Ziegelhoeffer T,Mees B,et al.A different outlook on the role of bone marrow stem cells in vascular growth:bone marrow delivers software not hardware.Circ Res,2004,94:573-574.
  • 7Kinnaird T,Stabile E,Burnett MS,et al.Marrow-derived stromal cells express genes encoding a broad spectrum of arterogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.Circ Res,2004,94:678-685.
  • 8Lee DC,Simonetti OP,Harris KR,et al.Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severit.Circulation,2004,110:58-65.
  • 9.

二级参考文献12

  • 1Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarctedmyocardium. Nature, 2001,410:701-705.
  • 2Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemicmyocardium by human bone-marrow-derived angioblasts prevents cardiomyocyteapoptosis, reduces remodeling and improves cardiac function. Nat Med, 2001,7:430-436.
  • 3Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis andangiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg, 2002,123:1132-1135.
  • 4Tang YL, Zhao Q, Zhang YC, et al. Autologous mesenchymal stem cell transplantationinduce VEGF and neovascularization in ischemic myocardium. Regulatory Peptiders, 2004,117:3-10.
  • 5Zhang S, Zhang P, Guo J, et al. Implantation of bone marrow cells upregulated expression of heat shock protein and VEGF in rat infarcted myocardium. Eur J Cardio Thorac Surg, 2004,25:188-195.
  • 6Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronaryprogenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI):mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation, 2003,108:2212-2218.
  • 7Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronarytransplantation of autologous bone marrow mesenchymal stem cell in patients with acutemyocardial infarction. Am J Cardiol, 2004,94:92-95.
  • 8Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 2004,364:141-148.
  • 9Goodell M, Brose K_Paradis G, Conner A, et al. Isolation and functional properties ofmurine hematopoietic stem cells that are replicating in vivo. J Exp Med, 1996,183:1797-1806.
  • 10Matsumoto N, Berman DS, Kavanagh PB, et al. Quantitative assessment of motionartifacts and validation of a new motion-correction program for myocardial perfusionSPECT. J Nucl Med, 2001,42:687-694.

共引文献4974

同被引文献147

引证文献19

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部